We are live on ! Find out more
Freestone Grove Partners

Freestone Grove Partners Portfolio holdings

AUM $15.6B Turnover 60.27%
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
Cap. Flow
+$81.1M
Cap. Flow %
0.52%
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Industrials 19.5%
2 Financials 16.81%
3 Miscellaneous 15.64%
4 Technology 13.57%
5 Healthcare 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IPAR icon
1176
Interparfums
IPAR
$3.71B
– –
-8,211
Closed -$746K –
IRON icon
1177
Disc Medicine
IRON
$3.05B
– –
-68,687
Closed -$4.39M –
ISRG icon
1178
Intuitive Surgical
ISRG
$155B
– –
-236,782
Closed -$109M –
ITRI icon
1179
Itron
ITRI
$3.71B
– –
-53,016
Closed -$4.75M –
ITW icon
1180
Illinois Tool Works
ITW
$78.3B
– –
-16,610
Closed -$4.32M –
JBI icon
1181
Janus International
JBI
$581M
– –
-29,825
Closed -$154K –
JBL icon
1182
Jabil
JBL
$29B
– –
-275,668
Closed -$73.2M –
JLL icon
1183
Jones Lang LaSalle
JLL
$14.2B
– –
-60
Closed -$18.3K –
JXN icon
1184
Jackson Financial
JXN
$8.83B
– –
-99,732
Closed -$10.5M –
KALV icon
1185
DELISTED
KalVista Pharmaceuticals
KALV
– –
-882,906
Closed -$17.8M –
KD icon
1186
Kyndryl
KD
$3.03B
– –
-1,261
Closed -$16.5K –
KEY icon
1187
KeyCorp
KEY
$22.2B
– –
-3,858,175
Closed -$77.4M –
KEYS icon
1188
Keysight
KEYS
$56.9B
– –
-592
Closed -$167K –
KHC icon
1189
The Kraft Heinz Company
KHC
$28.3B
– –
-2,092,664
Closed -$47.1M –
KMB icon
1190
Kimberly-Clark
KMB
$36B
– –
-486,963
Closed -$47M –
KNX icon
1191
Knight Transportation
KNX
$10.3B
– –
-23
Closed -$1.32K –
KRC icon
1192
Kilroy Realty
KRC
$4.05B
– –
-5
Closed -$141 –
KVYO icon
1193
Klaviyo
KVYO
$5.58B
– –
-206,730
Closed -$4.02M –
LAD icon
1194
Lithia Motors
LAD
$6.58B
– –
-1,811
Closed -$452K –
LAZ icon
1195
Lazard
LAZ
$3.57B
– –
-7,643
Closed -$325K –
LBRT icon
1196
Liberty Energy
LBRT
$2.71B
– –
-2,346
Closed -$67.6K –
LDOS icon
1197
Leidos
LDOS
$16B
– –
-7,208
Closed -$1.12M –
LEG icon
1198
DELISTED
Leggett & Platt
LEG
– –
-56,715
Closed -$560K –
LFST icon
1199
Lifestance Health
LFST
$4.65B
– –
-1
Closed -$6 –
LGND icon
1200
Ligand Pharmaceuticals
LGND
$6.11B
– –
-2,817
Closed -$562K –

Similar funds

Freestone Grove Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.

  • Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
  • Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
  • Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
  • Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
  • Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
  • Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
  • Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.